Clare O’Brien regularly advises major US and international clients on their public and private mergers and acquisition transactions, including public company restructurings, joint ventures and large public transactions.  She also provides counsel on corporate law questions, including corporate governance matters.

Ms. O’Brien has been consistently acknowledged as a leading M&A lawyer and has received numerous accolades including “Dealmaker of the Year”  by The American Lawyer, Top U.S.A. Women Dealmaker by the Global M&A Network 2021  as well as being named one of The Deal’s Top Women in Dealmaking 2021 and 2022 Lists for her work in Mergers & Acquisitions.

Prior to joining Shearman & Sterling, Ms. O’Brien worked with the law firm of Brady & Tarpey, P.C., where her practice included cross-border corporate transactions, litigation and domestic relations.  She began her legal career at the Irish law firm of Eugene F. Collins & Son.

• Representation of Raytheon Company in its recently completed combination with United Technologies Corporation
• Ardagh Group in various transactions, including its $8.3 billion “de-SPAC” transaction involving the combination of its metal packaging business with Gores Holdings V, Inc., a special purpose acquisition company, the combination of its Food & Specialty Metal Packaging business with Element Holdings II L.P., an entity controlled by The Ontario Teachers' Pension Plan, to form Trivium Packaging, its acquisition of certain metal beverage can manufacturing assets from Ball Corporation and Rexam PLC with an enterprise value of $3.42 billion, and its sale of Anchor Glass Container Corporation to an affiliate of KPS Capital Partners LP.
• Boston Scientific Corporation in various transactions, including its pending acquisition of BTG plc, a public company organized under the laws of England and Wales, its acquisition of the advanced biologic tissue capabilities of Neovasc Inc. and 15% of Neovasc’s common shares, its acquisition of the men’s health and prostate health businesses of Endo International plc, the sale of its neurovascular business to Stryker Corporation, its acquisition of and the restructuring of its interests in Advanced Bionics Corporation, its acquisition of Guidant Corporation, the sale of Guidant’s vascular businesses to Abbott Laboratories and in various corporate and other transactional matters
• HeartWare International, Inc. in its sale to Medtronic, Inc., and its terminated acquisition transaction with Thoratec Corporation
• Heidelberg Cement AG, in various transactions, including its sale of a cement plant and eight terminals to a subsidiary of the Colombian cement and concrete producer Cementos Argos S.A., and its sale of its building products business in North America (excluding Western Canada) and the United Kingdom to an affiliate of Lone Star Funds
• Mubadala Development Company, a public joint stock company wholly owned by the Government of the Emirate of Abu Dhabi, in various transactions, including its global business partnership with General Electric Company, its investment in the EBX Group (and related restructuring transactions) and its investment with Trafigura Pte. Ltd. in MMX Porte Sudeste
• Lafarge SA in various transactions, including the sale of its North American Gypsum business to an affiliate of Lone Star Funds, and the sale of certain aggregate and ready mix concrete assets to Bluegrass Materials Company, LLC, an affiliate of Lindsay Goldberg
• Corning Incorporated in various corporate and transactional matters, including its acquisitions of the fiber and copper connectivity solutions business of 3M Company, Axygen BioScience, Inc. and the Discovery Labware business of Becton, Dickinson and Company
• Bunge Limited in various transactions, including the sale of its Brazilian fertilizer business to Yara International ASA, its sale of Brazilian Fertilizer Nutrients Assets to Vale S.A., its acquisition of a controlling interest in Loders Croklaan Group B.V., its acquisition of Usina Moema Participações S.A. and its terminated merger agreement with Corn Products International, Inc.
• Danone in various transactions, including its acquisitions of The YoCrunch Company, YoCream International, Inc., and Medical Nutrition USA, Inc. and transactions with an affiliate of Kelso & Company, Suntory Water Group, The Coca-Cola Company, and Stonyfield Farm, Inc.
• SunGard Data Systems, Inc. in its acquisition by seven private equity funds led by Silver Lake Partners, the sale of its Higher Education businesses to affiliates of Hellman & Friedman LLC, and its split-off of SunGard Availability Services Inc.
• P.H. Glatfelter Company in various matters, including the sale of its Specialty Papers division to an affiliate of Lindsay Goldberg, its acquisition of certain manufacturing assets in Germany, Italy and France from subsidiaries of Georgia-Pacific LLC, and its acquisition of Concert Industries Corp. from Brookfield Special Situations Management Limited
• Fujifilm Holdings Corporation (Fujifilm) in connection with its acquisition of SonoSite, Inc.
• Quest Diagnostics Incorporated in various corporate and transactional matters, including its acquisition of Spectrum Laboratories Holdings, Inc., a portfolio company of Welsh, Carson, Anderson & Stowe, its 2011 acquisitions of Athena Diagnostics, Inc. and Celera Corporation and its acquisitions of AmeriPath Corporation, Unilab Corporation and the clinical laboratory business of SmithKline Beecham Corporation
• The Special Committee of HCA Inc. in connection with the acquisition of HCA by three private equity funds